SCHEMBL13786667

SCHEMBL13786667

CCCCOc1ccc(/C=N/c2ccccc2)c(OCCCC)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.48
▸ GAA P10253 2/20 0.48
▸ LMNA P02545 1/20 0.48
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ KDM4E B2RXH2 2/20 0.44
▸ POLB P06746 1/20 0.44
▸ NPY1R P25929 1/20 0.44
▸ NPY2R P49146 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ LTA4H P09960 2/20 0.44
▸ CYP1A2 P05177 1/20 0.43
▸ CYP19A1 P11511 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14221547 0.92 GAA (0.47) ALDH1A1GAALMNAMEN1KMT2A
SCHEMBL13786603 0.92 MAOB (0.53) ALDH1A1GAALMNAMEN1KMT2A
SCHEMBL14204715 0.89 DHODH (0.43) ALDH1A1GAALMNAMEN1KMT2A
SCHEMBL14206850 0.88 GAA (0.52) ALDH1A1GAALMNAMEN1KMT2A
SCHEMBL14035606 0.86 GAA (0.46) ALDH1A1GAALMNAMEN1KMT2A
SCHEMBL13786439 0.86 MAOB (0.46) ALDH1A1GAALMNAMEN1KMT2A
SCHEMBL13971251 0.83 ALDH1A1 (0.47) ALDH1A1GAALMNAMEN1KMT2A
SCHEMBL13971253 0.82 ALDH1A1 (0.43) ALDH1A1GAALMNAMEN1KMT2A
SCHEMBL10533050 0.81 GAA (0.54) ALDH1A1GAALMNAMEN1KMT2A
SCHEMBL14221634 0.80 MAOB (0.46) ALDH1A1GAALMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090186834-A1 DIPHENYLHETEROCYCLE CHOLESTEROL ABSORPTION INHIBITORS MICROBIA, INC. (US) 2009-07-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090186834-A1 DIPHENYLHETEROCYCLE CHOLESTEROL ABSORPTION INHIBITORS NPC1L1, CYP46A1, NPC1 ALDH1A1 1290/4885GAA 279/4885LMNA 2056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback